ORKA
Price
$12.22
Change
+$0.54 (+4.62%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
457.52M
PCVX
Price
$34.80
Change
+$0.96 (+2.84%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
4.49B
68 days until earnings call
Interact to see
Advertisement

ORKA vs PCVX

Header iconORKA vs PCVX Comparison
Open Charts ORKA vs PCVXBanner chart's image
Oruka Therapeutics
Price$12.22
Change+$0.54 (+4.62%)
Volume$1.64K
Capitalization457.52M
Vaxcyte
Price$34.80
Change+$0.96 (+2.84%)
Volume$34.28K
Capitalization4.49B
ORKA vs PCVX Comparison Chart
Loading...
ORKA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORKA vs. PCVX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORKA is a Buy and PCVX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ORKA: $12.22 vs. PCVX: $34.80)
Brand notoriety: ORKA and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORKA: 56% vs. PCVX: 40%
Market capitalization -- ORKA: $457.52M vs. PCVX: $4.49B
ORKA [@Biotechnology] is valued at $457.52M. PCVX’s [@Biotechnology] market capitalization is $4.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORKA’s FA Score shows that 1 FA rating(s) are green whilePCVX’s FA Score has 1 green FA rating(s).

  • ORKA’s FA Score: 1 green, 4 red.
  • PCVX’s FA Score: 1 green, 4 red.
According to our system of comparison, PCVX is a better buy in the long-term than ORKA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORKA’s TA Score shows that 5 TA indicator(s) are bullish while PCVX’s TA Score has 2 bullish TA indicator(s).

  • ORKA’s TA Score: 5 bullish, 4 bearish.
  • PCVX’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, ORKA is a better buy in the short-term than PCVX.

Price Growth

ORKA (@Biotechnology) experienced а +3.12% price change this week, while PCVX (@Biotechnology) price change was +6.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

ORKA is expected to report earnings on Mar 06, 2025.

PCVX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4.49B) has a higher market cap than ORKA($458M). ORKA YTD gains are higher at: -39.763 vs. PCVX (-58.661). PCVX has more cash in the bank: 1.67B vs. ORKA (411M). ORKA has less debt than PCVX: ORKA (988K) vs PCVX (87.2M).
ORKAPCVXORKA / PCVX
Capitalization458M4.49B10%
EBITDAN/A-512.62M-
Gain YTD-39.763-58.66168%
P/E RatioN/AN/A-
RevenueN/A0-
Total Cash411M1.67B25%
Total Debt988K87.2M1%
FUNDAMENTALS RATINGS
ORKA: Fundamental Ratings
ORKA
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORKAPCVX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 17 days ago
80%
Declines
ODDS (%)
Bearish Trend about 1 month ago
81%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ORKA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BLCN22.330.36
+1.63%
Siren Nasdaq NexGen Economy ETF
DGS53.700.43
+0.81%
WisdomTree Emerging Markets SmCp Div ETF
DFCA49.060.01
+0.02%
Dimensional California Municipal Bd ETF
HSCZ34.60N/A
N/A
iShares Currency Hdgd MSCI EAFE SmCp ETF
XTR26.81N/A
N/A
Global X S&P 500® Tail Risk ETF

ORKA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORKA has been loosely correlated with PCVX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ORKA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORKA
1D Price
Change %
ORKA100%
-2.18%
PCVX - ORKA
43%
Loosely correlated
-2.34%
RLFTF - ORKA
31%
Poorly correlated
-5.03%
ENTX - ORKA
29%
Poorly correlated
-1.20%
CMMB - ORKA
24%
Poorly correlated
+0.43%
RLFTY - ORKA
24%
Poorly correlated
-6.68%
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with LOGC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-2.34%
LOGC - PCVX
45%
Loosely correlated
-5.38%
ORKA - PCVX
43%
Loosely correlated
-2.18%
DYN - PCVX
41%
Loosely correlated
+1.06%
DNLI - PCVX
40%
Loosely correlated
+3.52%
STOK - PCVX
38%
Loosely correlated
+0.37%
More